Alzheimers Disease From Basic Research To Clinical Applications
Download Alzheimers Disease From Basic Research To Clinical Applications full books in PDF, epub, and Kindle. Read online free Alzheimers Disease From Basic Research To Clinical Applications ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Hermann J. Gertz |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 313 |
Release |
: 2013-06-29 |
ISBN-10 |
: 9783709175088 |
ISBN-13 |
: 3709175089 |
Rating |
: 4/5 (88 Downloads) |
Synopsis Alzheimer’s Disease - From Basic Research to Clinical Applications by : Hermann J. Gertz
As human longevity continues to be extended, so will the impact of age-associated dementia on individual lives and society. Alzheimer’s disease as the most common cause of dementia in the elderly remains a sentinal problem and its underlying pathology is still poorly understood. Available therapeutic strategies require considerable refinement and the development of new therapeutic strategies need input from basic research. Thus continued efforts are necessary both to understand basic mechanisms of the condition and to achieve more powerfull therapies. This volume brings together the reports of basic scientists and clinical investigators. The chapters provide a spectrum of information valuable for clinicians and scientists. This issue bridges the gap between laboratory work in basic science and the development of urgently needed therapeutic strategies. Areas presented are the molecular and cellular biology of the disease, pathogenetic mechanisms and potential therapeutic targets, genetics, risk factors, strategies of prevention and treatment as well as practical aspects of medical and social care for patients with Alzheimer’s disease.
Author |
: Jeffrey Cummings |
Publisher |
: Cambridge University Press |
Total Pages |
: 575 |
Release |
: 2022-03-31 |
ISBN-10 |
: 9781108838665 |
ISBN-13 |
: 1108838669 |
Rating |
: 4/5 (65 Downloads) |
Synopsis Alzheimer's Disease Drug Development by : Jeffrey Cummings
Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models.
Author |
: Karl Herrup |
Publisher |
: MIT Press |
Total Pages |
: 269 |
Release |
: 2023-03-07 |
ISBN-10 |
: 9780262546010 |
ISBN-13 |
: 0262546019 |
Rating |
: 4/5 (10 Downloads) |
Synopsis How Not to Study a Disease by : Karl Herrup
An authority on Alzheimer's disease offers a history of past failures and a roadmap that points us in a new direction in our journey to a cure. For decades, some of our best and brightest medical scientists have dedicated themselves to finding a cure for Alzheimer's disease. What happened? Where is the cure? The biggest breakthroughs occurred twenty-five years ago, with little progress since. In How Not to Study a Disease, neurobiologist Karl Herrup explains why the Alzheimer's discoveries of the 1990s didn't bear fruit and maps a direction for future research. Herrup describes the research, explains what's taking so long, and offers an approach for resetting future research. Herrup offers a unique insider's perspective, describing the red flags that science ignored in the rush to find a cure. He is unsparing in calling out the stubbornness, greed, and bad advice that has hamstrung the field, but his final message is a largely optimistic one. Herrup presents a new and sweeping vision of the field that includes a redefinition of the disease and a fresh conceptualization of aging and dementia that asks us to imagine the brain as a series of interconnected "neighborhoods." He calls for changes in virtually every aspect of the Alzheimer's disease research effort, from the drug development process, to the mechanisms of support for basic research, to the often-overlooked role of the scientific media, and more. With How Not to Study a Disease, Herrup provides a roadmap that points us in a new direction in our journey to a cure for Alzheimer's.
Author |
: Kathrin Herrmann |
Publisher |
: BRILL |
Total Pages |
: 749 |
Release |
: 2019-04-30 |
ISBN-10 |
: 9789004391192 |
ISBN-13 |
: 9004391193 |
Rating |
: 4/5 (92 Downloads) |
Synopsis Animal Experimentation: Working Towards a Paradigm Change by : Kathrin Herrmann
Animal experimentation has been one of the most controversial areas of animal use, mainly due to the intentional harms inflicted upon animals for the sake of hoped-for benefits in humans. Despite this rationale for continued animal experimentation, shortcomings of this practice have become increasingly more apparent and well-documented. However, these limitations are not yet widely known or appreciated, and there is a danger that they may simply be ignored. The 51 experts who have contributed to Animal Experimentation: Working Towards a Paradigm Change critically review current animal use in science, present new and innovative non-animal approaches to address urgent scientific questions, and offer a roadmap towards an animal-free world of science.
Author |
: Walter George Bradley |
Publisher |
: |
Total Pages |
: 1672 |
Release |
: 2004 |
ISBN-10 |
: 0750674695 |
ISBN-13 |
: 9780750674690 |
Rating |
: 4/5 (95 Downloads) |
Synopsis Neurology in Clinical Practice by : Walter George Bradley
New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.
Author |
: Michael R. Hamblin |
Publisher |
: Academic Press |
Total Pages |
: 658 |
Release |
: 2019-07-13 |
ISBN-10 |
: 9780128153062 |
ISBN-13 |
: 0128153067 |
Rating |
: 4/5 (62 Downloads) |
Synopsis Photobiomodulation in the Brain by : Michael R. Hamblin
Photobiomodulation in the Brain: Low-Level Laser (Light) Therapy in Neurology and Neuroscience presents the fundamentals of photobiomodulation and the diversity of applications in which light can be implemented in the brain. It will serve as a reference for future research in the area, providing the basic foundations readers need to understand photobiomodulation's science-based evidence, practical applications and related adaptations to specific therapeutic interventions. The book covers the mechanisms of action of photobiomodulation to the brain, and includes chapters describing the pre-clinical studies and clinical trials that have been undertaken for diverse brain disorders, including traumatic events, degenerative diseases and psychiatric disorders. - Provides a much-needed reference on photobiomodulation with an unprecedented focus on the brain and its disorders - Features a body of world-renowned editors and chapter authors that promote research, policy and funding - Discusses the recent and rapid accumulation of literature in this area of research and the shift towards the use of non-invasive techniques in therapy
Author |
: Don Kulasiri |
Publisher |
: World Scientific |
Total Pages |
: 416 |
Release |
: 2022-01-06 |
ISBN-10 |
: 9781800610132 |
ISBN-13 |
: 1800610130 |
Rating |
: 4/5 (32 Downloads) |
Synopsis Alzheimer's Disease: Biology, Biophysics And Computational Models by : Don Kulasiri
Alzheimer's disease (AD) is the leading cause of dementia and, unfortunately, remains incurable. The social, emotional and financial implications of AD are immeasurable, and about 47 million people worldwide are affected by AD or other forms of dementia. As lifespans are improved by healthcare systems worldwide, age-associated neurodegenerative diseases are imposing an increasing challenge to science. It is becoming imperative for us to understand the causes of these diseases, AD in particular, at molecular and cellular levels. Starting with the broader picture from a biological perspective, this book takes the reader through fascinating dynamics within and outside of neurons in the brain.Alzheimer's Disease: Biology, Biophysics and Computational Models helps the reader to understand AD from mechanistic and biochemical perspectives at intra- and inter-cellular levels. It focuses on biochemical pathways and modeling associated with AD. Some of the recent research on biophysics and computational models related to AD are explained using context-driven computational and mathematical modeling and essential biology is discussed to understand the modeling research.
Author |
: Jason Karlawish |
Publisher |
: St. Martin's Press |
Total Pages |
: 269 |
Release |
: 2021-02-23 |
ISBN-10 |
: 9781250218742 |
ISBN-13 |
: 1250218748 |
Rating |
: 4/5 (42 Downloads) |
Synopsis The Problem of Alzheimer's by : Jason Karlawish
A definitive and compelling book on one of today's most prevalent illnesses. In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050. Part case studies, part meditation on the past, present and future of the disease, The Problem of Alzheimer's traces Alzheimer’s from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems’ failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer’s to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life. Rich in science, history, and characters, The Problem of Alzheimer's takes us inside laboratories, patients' homes, caregivers’ support groups, progressive care communities, and Jason Karlawish's own practice at the Penn Memory Center.
Author |
: Elaine A. Moore |
Publisher |
: McFarland |
Total Pages |
: 233 |
Release |
: 2020-04-02 |
ISBN-10 |
: 9781476678610 |
ISBN-13 |
: 1476678618 |
Rating |
: 4/5 (10 Downloads) |
Synopsis Alzheimer's Disease and Infectious Causes by : Elaine A. Moore
With the recent discovery that amyloid beta protein, the cause of plaques in Alzheimer's disease, is an antimicrobial peptide produced in response to infection, many researchers are focusing on the role infection plays in the development of Alzheimer's disease. Brain studies have also identified a number of different viruses, bacteria, fungi, and protozoa in the postmortem brain specimens of Alzheimer's patients. Infection (particularly chronic, latent and persistent infections) causes an immune response that leads to inflammation and brain cell degeneration, which are characteristic features of Alzheimer's disease. Sources of infection in Alzheimer's disease vary from childhood infections to gut microbes that find their way into the brain as a result of aging, leaky gut syndrome, and increased permeability of the blood brain barrier. Studies and ongoing clinical trials show that treatment of viral and bacterial infections, as well as restoring a healthy balance to the gut microbiome, can reduce disease risk and improve symptoms in patients with Alzheimer's disease. This book serves as an introduction to the human microbiome and the role that infection plays in the development of Alzheimer's disease.
Author |
: Athanasios Alexiou |
Publisher |
: Frontiers Media SA |
Total Pages |
: 501 |
Release |
: 2019-12-04 |
ISBN-10 |
: 9782889631285 |
ISBN-13 |
: 2889631281 |
Rating |
: 4/5 (85 Downloads) |
Synopsis The Alzheimer's Disease Challenge by : Athanasios Alexiou
Alzheimer’s disease is undoubtedly the major health challenge of our Century with significant social and economic consequences. This Frontiers eBook offers a contribution of 39 innovative papers on the multidimensional and crucial problem of Alzheimer’s disease management and treatment. Several perspectives, research updates, and trials describing methods on potential diagnosis and treatment are presented including biological mechanisms, biomarkers and risk factors for an early and efficient prognosis, diagnosis and prevention. Additionally, while the rapidly increasing Alzheimer’s disease population demands holistic solutions and clinical studies with new therapeutic target approaches, several of the contributive papers present promising drugs targeting Alzheimer’s disease treatment. We give our deepest acknowledgment to all the authors for their important and innovative contributions, to the reviewers for their valuable recommendations on improving the submitting studies and all the Frontiers Editorial team for continuous support.